Chimeric antigen receptor (CAR) T cell therapy has changed the treatment landscape for certain blood cancers. Standardizing CAR T cell manufacturing is one of the key considerations for improving production standards, reducing variability, and maximizing clinical safety and efficacy.
Download this article from Thermo Fisher Scientific to learn how closed, integrated, and automated instrument workflows improve CAR T cell manufacturing.
Top Image Credit:
iStock
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development.
An improved chromatography membrane elution method helps scientists achieve higher yields of pure plasmid DNA.
By fine-tuning polishing conditions, scientists attain high titers of infectious lentiviral particles during purification.
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
New fluidics and clog detection systems further simplify operation and reduce instrument downtime
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Study identifies new metrics to enhance scRNA-seq based virtual cell modelling
